The United States health care industry is a massive business, and the pharmaceutical industry is one of the largest industries in the country.

As of January 1, there were more than 11.7 million employees working in the industry, according to the latest data from the Federal Bureau of Economic Research.

It’s the third-largest in the world, behind only the US Postal Service and the United Kingdom’s Royal Mail.

In addition to the pharmaceutical companies, there are also a lot of other companies that help to run the industry.

They include:Boeing and other aerospace firms, the food and beverage industries, and other industries that make consumer goods.

And, of course, there’s the healthcare industry.

The top five drugs for the top 20% of US consumers are:Aminoglycosides for the elderly and the disabled.

Cialis for people with pre-existing conditions.

Humira for people at high risk for COVID-19.

Naltrexone for people on opioid and HIV medication.

In total, there is about $3 trillion in annual pharmaceutical spending in the United States, according the Department of Health and Human Services.

These costs are passed along to consumers and their doctors, as well as to the US economy as a whole.

But what’s it all for?

There’s a lot going on here.

The bottom line:The biggest drug companies make a lot more money than the average American, but there’s also a very small percentage of the US population who will benefit from their services.

The top 20 percent of consumers spend about $8,600 a year on their health care, and they’re just the top 5% of the population.

In fact, the top 1% of consumers spent $19,000 a year in the health care sector in 2014, according a recent analysis from The Economic Policy Institute.

The industry is also dominated by a very narrow set of people.

The majority of patients are on Medicaid and Medicare, the federal healthcare programs for the poor and elderly.

But there’s a big difference in how they spend their money, with the top 10% of Americans spending an average of about $11,000 annually.

That’s up about 50% from 2014, when the top 25% of households spent $10,000 on their healthcare.

It’s a huge difference, and it shows up in many ways.

The pharmaceutical industry makes about $2.4 trillion in sales annually.

Of that, the average company makes about a third, and in some cases, even more, depending on the drugs and their price.

That makes up more than 50% of all pharmaceutical sales.

That’s a relatively small amount compared to the $3.6 trillion the pharmaceuticals industry earned last year, which is still more than double the industry’s entire revenue in 2015.

But while the pharmaceutical business is dominated by the wealthy, the health-care industry is far from the only sector that benefits from pharmaceuticals.

A report from the Institute for Healthcare Improvement, a research organization in Washington, DC, showed that the health insurance industry contributes an estimated $1.3 trillion a year to the overall economy.

It makes up about 22% of total GDP, and that figure grows with each year of health insurance premiums.

The second largest industry is real estate, which has an estimated 4.4 million jobs in the U.S. That industry makes up roughly one-third of total employment.

And the average home buyer pays $1,000 more a year than the typical person earning just $15,000.

In all, the industry is estimated to cost the economy $6.3 billion a year, according an analysis from the Committee for a Responsible Federal Budget, an advocacy group.

So the fact that the industry makes a lot and the companies that make a big amount make a good amount is not a bad thing.

But in terms of overall spending, the cost of healthcare in the US is a big, big problem.

The average American spends about $22,000 for their healthcare, according its latest estimates.

And for most of us, that’s a pretty big number.